Objective: A quality improvement initiative was employed to decrease single institution surgical site infection rate in open lower extremity revascularization procedures. Summary background data: In an attempt to lower patient morbidity, we developed and implemented the Preventative Surgical Site Infection Protocol in Vascular Surgery. Surgical site infections lead to prolonged hospital stays, adjunctive procedure, and additive costs. We employed targeted interventions to address the common risk factors that predispose patients to post-operative complications. Methods: Retrospective review was performed between 2012 and 2016 for all surgical site infections after revascularization procedures of the lower extremity. A quality improvement protocol was initiated in January 2015. Primary outcome was the assessment of surgical site infection rate reduction in the pre-protocol vs. post-protocol era. Secondary outcomes evaluated patient demographics, closure method, perioperative antibiotic coverage, and management outcomes. Results: Implementation of the protocol decreased the surgical site infection rate from 6.4% to 1.6% p ¼ 0.0137). Patient demographics and comorbidities were assessed and failed to demonstrate a statistically significant difference among the infection and no-infection groups. Wound closure with monocryl suture vs. staple proved to be associated with decreased surgical site infection rate (p < 0.005). Conclusions: Preventative measures, in the form of a standardized protocol, to decrease surgical site infections in the vascular surgery population are effective and necessary. Our data suggest that there may be benefit in the incorporation of MRSA and Gram-negative coverage as part of the Surgical Care Improvement Project perioperative guidelines.
Introduction
The 1999 Institute of Medicine report, To Err is Human, stated that the burden of preventable medical errors is greater than $29 billion annually. These " [medical] errors . . . are costly in terms of loss of trust in the health care system by patients and diminished satisfaction by both patients and health professionals. 1 " Over the years, a growing public attention has resulted in policy changes. Readmission rates have become a quality healthcare metric due to the Patient Protection and Affordable Care Act of 2010, resulting in hospital penalization by the Centers for Medicare and Medicaid Services (CMS). 2, 3 Vascular surgical procedures are not yet part of the list of medical conditions penalized by the CMS, which includes: acute myocardial infarction, heart failure, pneumonia, total knee and hip arthroplasties. 2 Perhaps this is appropriate as the high readmission rates for vascular patients, which range from 12% to 24% within a 30-day period, are not reflective of planned procedures, NYU Lutheran, Brooklyn, NY, USA unrelated hospital admissions, and the chronic nature and progression of peripheral vascular disease. 2, 4, 5 Nonetheless, following hospital discharge, the most common reason for readmission in the surgical patient population is a post-operative complication. 6 Our vascular service noted an elevated readmission and surgical site infection (SSI) rate between 2012 and 2014. Thus, it led to the implementation of quality improvement initiatives targeted to decrease readmission rates, lower hospital costs, and minimize patient morbidity. We understand that the use of clinical protocols allows for standardization of care across the patient population, minimizes operator error, improves interdisciplinary communication, and allows for an internal audit for quality of care. Thus, one component of these initiatives led to the development of the Preventative Surgical Site Infection Protocol in Vascular Surgery by senior author EA. We examined the impact of our standardized protocol in patients undergoing open lower extremity revascularization procedures.
Methods
The two surgeons EA and AH changed hospital locations of their busy vascular surgical practice in 2012. Over the next two years, there was an incremental increase in the total SSI rate of the lower extremities ( Figure 1 ). A quality improvement initiative was subsequently undertaken, and a retrospective review of patient data was performed between March 2012 and May 2016.
All patients with elective and emergent open revascularization procedures involving a femoral incision were examined: axillary-femoral bypasses, femoralfemoral bypasses, infrainguinal-arterial bypasses, and open thrombectomies. Documented method of closure as well as length of follow-up were part of the inclusion criteria. As per the Center of Disease Control and Prevention (CDC) definitions of SSIs, superficial SSIs were monitored for 30 days for both primary and secondary incisions. Deep SSIs were monitored for up to 90 days for both primary and secondary incisions. 7 Patients who failed to meet inclusion criteria, or had lack of documentation of the above, were excluded from the review.
A protocol targeting skin colonization, hematoma formation, lymphorrhea, devitalization of tissue, contamination, and lack of skin edge apposition (Figure 2 ) was created. These factors were chosen based on surgeon experience. The primary outcome examined was the SSI rate reduction before and after introduction of the proposed protocol, which was implemented on 1 January 2015 (Figure 2 ). December 2014 acted as a transition period for all staff to familiarize themselves with the perioperative components of the protocol. Only vascular surgeons, EA and AH, were included in this analysis. Secondary measures examined were patient demographics, presenting symptoms, skin closure method (staple vs. running monocryl suture), perioperative antibiotics, wound culture results, and management outcomes of infected wounds. This was performed by comparing all patients that sustained an SSI (n ¼ 18, SSI group) to a random cohort of patient that met inclusion criteria and did not sustain a SSI (n ¼ 17, no-SSI group).
The components of Preventative Surgical Site Infection Protocol in Vascular Surgery intervene in the pre-operative, intra-operative, and post-operative period. Figure 3 includes an overview of the protocol. Pre-operatively, once the need for open revascularization is established, the patient does so either on an elective or emergent basis. If the patient is admitted to the hospital for optimization prior to surgery, they are put on daily 2% chlorhexidine baths. On the day of surgery, both the urgent and elective patients undergo hair clipping outside of the operating room, with the use of 4% chlorhexidine wipes. At this time, the skin is assessed by the operating surgeon for any lesions or wounds that would alter the surgical approach and areas of planned incisions. Intraoperatively, several key points are stressed: avoiding the use of cautery on the skin edges; minimizing the creation of multiple tissue planes and extensive undermining of tissue; decreasing unnecessary traction on the skin for prolonged periods of time; identification and ligation of all lymphatic channels; meticulous hemostasis; two-layer skin closure performed by fellow or vascular surgeon to assure perfect apposition of skin edges using running monocryl suture; application of skin glue to reinforce closure of incisions. Post-operatively, the sterile gauze dressing applied in the operating room is left in place for 48-72 h, as long as it remains dry to avoid contamination.
Statistical analysis using Chi-squares and Fisher's exact test was performed where appropriate using IBM SPSS Statistics v22 software.
Results
A total of 221 lower extremity revascularizations were performed beginning March 2012, with 15 SSI's, prior to implementation of the protocol in January 2015 ( Figure 3 ). Following initiation of the Preventative Surgical Site Infection Protocol in Vascular Surgery, there were 189 cases that met inclusion criteria and a reduction to three SSIs for the year 2015, and none reported to date in 2016 at the conclusion of our study. Overall, our SSI rate pre-protocol and postprotocol was 6.8% and 1.6%, respectively (p ¼ 0.0137) (Figure 4) . Table 1 reflects the patient demographics of the no-SSI vs. SSI groups. Age, gender, race, body mass index, comorbidities, hypoalbuminemia, history of smoking, and revascularization procedures in the last 30 days failed to demonstrate a statistically significant difference.
The perioperative characteristics of the no-SSI vs. SSI groups are depicted in Table 1 . There was no statistically significant difference in the American Society of Anesthesiologist Physical Status Classification System (ASA) between the two groups. Femoral cut down's including open thrombectomies were only noted in the infected group and femoral-distal open revascularizations were only noted in the no-infection group (p < 0.001). Autologous venous conduits were less likely to be infected (Table 1) (p < 0.001). The estimated blood loss and operative time were slightly lower in the SSI group, but no statistically significant difference was noted (Table 1) .
In accordance with the Surgical Care Improvement Project (SCIP) guidelines, all of our patients received antibiotics within 1 h of incision. The antibiotic of choice, unless the patients had a penicillin allergy, was Ancef (cefazolin). There was no standard protocol incorporating the administration of vancomycin (vanconin), unless it was the preoperative antibiotic the patients were receiving as part of their treatment. Seventy percent (n ¼ 14) of patients who received vancomycin (vanconin) were found in the no-SSI group vs. 85% (n ¼ 11) of patients who received Ancef (Cefazolin) in the SSI group. Gram-negative (GN) bacteria were predominant in cultures of infected surgical wounds when compared to Gram-positive (GP) organisms, 72 % vs. 12%, respectively (Table 2) .
Examining the management of infected incisions post-operatively, 11% of all infections (n ¼ 17) were managed conservatively with a hospital admission and intravenous antibiotic regimen. The remainder of patients required operative exploration with 6% (n ¼ 1) requiring excision of graft.
The closure method was assessed to be a risk factor for prevalence of SSIs. As seen in Figure 5 , the number of patients with staple closure was significantly more prevalent in the SSI group (p < 0.005).
Discussion
Approximately 16 million operative procedures were performed in acute care hospitals within the United States in 2010. As per the CDC, SSIs were the most common healthcare-associated infection (HAI) and accounted for 31% of all HAI. 7 SCIP was implemented 10 years ago to improve the safety and quality of patient care. The efficacy of SCIP measures on peripheral bypass patients has been questionable, with reports of no impact on the pre-SCIP vs. post-SCIP era. 8 Reduction in SSI rate within the vascular surgery patient population can improve patient morbidity and provide better quality care. The data vary depending on the population studied, but reports of SSIs in the lower extremity bypass patients range from 11% to 39%. 9 Those who sustain SSIs were 5 times more likely to get readmitted to the hospital, 60% required intensive unit care, and mortality rates were double of their non-SSI counterparts. 10 Our own qualitative review of patients with SSI was the impetus to develop a quality improvement project, which led us to develop and implement the Preventative Surgical Site Infection Protocol in Vascular Surgery. The overall impact of the protocol was a SSI rate reduction of 76%, and an SSI rate of 1.6%. To our knowledge, the lowest reported SSI rate in literature for groin vascular procedures is approximately 3%.
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In our cohort, three patients over an 18-month period developed SSI. Our chart review demonstrated that two of these patients violated protocol as the skin was approximated using staples. The third patient required re-exploration of his groin during the same admission due to complications of the index procedure.
There are a multitude of risk factors that play a role in SSI development. The most common known risk factors for SSI are female gender, obesity, diabetes, CAD, smoking, chronic obstructive pulmonary disease, prolonged operative time, and infrainguinal incisions. 12 The comparison between the SSI and no-SSI groups failed to show a statistically significant difference in patient demographics, comorbidities, and ASA classification (Table 1 ). There were no femoral-distal revascularizations in the SSI group and no open thrombectomies in the no-SSI group. It is unclear if this uneven distribution is due to the small sample size or that greater care was taken with high-risk distal revascularizations. This presents itself as an opportunity for improvement and further study.
We believe that meticulous apposition of the skin is key to avoiding contamination of surgical wounds. Figure 1 illustrates what can be labeled as "adequate" closure. Our surgical patient population is composed of high-risk vasculopathies. Thus, we incorporated twolayer closure, with running monocryl suture for the skin into our protocol. The results support this speculation and demonstrate the association between staple closure and SSI (Figure 2 ). Skin apposition should be performed with greatest of care prior to leaving the operating room, a concept that extends beyond open lower extremity revascularization procedures.
Calligaro et.al. 13 conducted a study examining management of infected groins following arterial bypass surgery. Comparing the bacterial distribution in wound cultures, there were 97% of cultures containing GN and 79% GP organisms. Our study demonstrated a significantly lower incidence of GP organisms (12%), but a similar GN organism incidence of 72% (Table 2) . Methicillin-resistant Staphylococcus aureus (MRSA) decolonization is frequently performed in the perioperative period using chlorhexidine and mupirocin in the cardiac, knee, and hip surgical patients.
14 Employment of chlorhexidine baths has also shown to decrease MRSA acquisition. 15 Chlorhexidine wipes and baths were used in the pre-operative period in all of our patients. Additionally, there was an association with lower SSI rates in those who received vancomycin. The known prevalence of GN organisms in wound cultures of groin SSIs warrants further attention. Additional studies need to be performed for the standardization of MRSA and GN organism coverage to the perioperative antibiotic regimen.
Limb salvage attempts in patients with peripheral vascular disease are compromised by SSIs, even in the setting of patent grafts. 16 In our study, 89% of the patients required operative intervention for their SSI. Interventions were tailored to individual patients. They included but were not limited to wound exploration and washout, with and without application of negative pressure dressing therapy. One patient required excision of graft. Avoiding the morbidity, and possible limb loss, secondary to SSIs can be accomplished with inexpensive measures that utilize existing resources.
Conclusion
We have demonstrated that implementing a standardized protocol in the perioperative period led to a reduction in our SSI rate. Although not quantified in this review, this improved patient satisfaction, reduced hospital costs secondary to readmissions, and lowered patient morbidity. The incorporation of GN and MRSA antibiotic prophylaxis into the pre-operative antibiotic regimen is an area that requires further attention.
